
Home » J&J Settles Risperdal Lawsuit on Opening Day of Trial
J&J Settles Risperdal Lawsuit on Opening Day of Trial
September 11, 2012
Johnson & Johnson settled a lawsuit on the first day of a trial over claims its antipsychotic drug Risperdal (risperidone) caused a male plaintiff to grow breast tissue, one of his lawyers told a state judge in Philadelphia.
Bloomberg
Bloomberg
Upcoming Events
-
26Jan
-
27Jan
-
27Jan
-
09Feb
-
10Feb
-
11Feb